Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

PCOS has many symptoms, with high androgen levels being the most common.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Hyperthyroidism can hide signs of high androgen levels in females.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Skin symptoms often reveal hormonal imbalances in PCOS.

The document concludes that effectively managing PCOS requires a multifaceted approach.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.